Registry of Asthma Characterization and Recruitment 3 (RACR3)

Recruiting now

Conditions studied: Asthma

In brief

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Key facts

Study ID

NCT05272241

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

1500

Starts

2022-04-15

Expected to finish

2028-05-01

Last updated by the study team

2025-06-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant is either:
• At least 18 years old, willing and able to provide informed consent at the time of enrollment
• Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
• Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)

You may not qualify if…

• Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
• Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
• Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
• Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
• Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.

Where it is running

• Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site — Washington D.C., District of Columbia, United States (enrolling)
• Cincinnati Children's Hospital Medical Center: Asthma Center — Cincinnati, Ohio, United States (enrolling)
• Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology — Chicago, Illinois, United States (enrolling)
• Children's Hospital Colorado: Allergy Program — Aurora, Colorado, United States (enrolling)
• Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute — New York, New York, United States (enrolling)
• Boston Children's Hospital: Department of Immunology — Boston, Massachusetts, United States
• Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.